Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NCPC Hebei Huamin Pharmaceutical is a major subsidiary of the North China Pharmaceutical Group (NCPC), specializing in the production of anti-infective drugs. Based in Shijiazhuang, China, the company operates one of Asia's largest and most advanced manufacturing bases for cephalosporin antibiotics. Its product portfolio includes a comprehensive range of sterile powders for injection and oral dosage forms, all manufactured under strict international GMP standards. Huamin plays a critical role in NCPC's global supply chain, exporting high-quality active pharmaceutical ingredients and finished dosages to numerous international markets. The company is recognized for its highly automated production lines and its focus on large-scale, cost-effective antibiotic synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NCPC Hebei Huamin Pharmaceutical.